RECRUITING

Evaluating the Technology and Assessing the Biological Effects of Commercially Available PhotoBioModulation Devices

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Photobiomodulation therapy (PBMT) involves applying non-ionizing forms of light from sources including lasers, LEDs, and broadband light, in the visible and near infrared spectrum, to the body to enhance performance, stimulate healing, modulate recovery, and improve health. The investigators will conduct a single-blinded randomized-control trial with sham control to investigate the effectiveness of providing PBMT in a military population, translating this cutting-edge research to application in the operational setting.

Official Title

Evaluating the Technology and Assessing the Biological Effects of Commercially Available PhotoBioModulation Devices

Quick Facts

Study Start:2024-03-11
Study Completion:2028-09-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06403644

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 45 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Active-duty military personnel, government civilians, and government contractors
  2. 2. Between the ages of 18-45 years old (inclusive)
  3. 3. Ability to read and understand English language
  4. 4. Willingness and ability to commit to study procedures, including study intervention and follow-up
  1. 1. Body fat \> 40%
  2. 2. Weight exceeds 300lbs
  3. 3. Height exceeds 7ft 3in
  4. 4. \> 10% of full body coverage of tattoos
  5. 5. Cardiovascular disease requiring medical management
  6. 6. Currently utilizing a pacemaker
  7. 7. Currently utilizing select medications (e.g., statins, diuretics, antihypertensive agents)
  8. 8. Currently utilizing medications associated with sensitivity to heat or light (e.g., amiodarone, chlorpromazine, doxycycline, hydrochlorothiazide, nalidixic acid, naproxen, piroxicam, tetracycline, thioridazine, voriconazole)
  9. 9. Currently undergoing treatment for a brain-related injury
  10. 10. Diagnosis of autoimmune diseases
  11. 11. Diagnosis of porphyria (light induced allergy) or photosensitive eczema
  12. 12. Diagnosis of Cancer
  13. 13. Diagnosis of epilepsy and/or being seizure prone
  14. 14. Diagnosis of diabetes
  15. 15. Diagnosis of Lupus Erythematosus
  16. 16. Diagnosis of retinal disease
  17. 17. Uncontrolled thyroid disease (known problem with no medical management)
  18. 18. Cirrhosis of the liver
  19. 19. Impaired blood clotting (from medication or underlying condition)
  20. 20. Photophobia
  21. 21. Albinism/achromasia
  22. 22. Currently pregnant or plan to become pregnant during the study (6 weeks)
  23. 23. Currently participating in any other intervention-based research studies other than protocol FWR20220097H that may confound results.

Contacts and Locations

Study Contact

Margaret E Hollander
CONTACT
7038634124
Mhollander@Genevausa.org

Principal Investigator

Jason Eckerle
PRINCIPAL_INVESTIGATOR
United States Air Force Research Laboratory

Study Locations (Sites)

Wright Patterson Air Force Base
Beavercreek, Ohio, 45324
United States

Collaborators and Investigators

Sponsor: United States Air Force Research Laboratory

  • Jason Eckerle, PRINCIPAL_INVESTIGATOR, United States Air Force Research Laboratory

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-03-11
Study Completion Date2028-09-01

Study Record Updates

Study Start Date2024-03-11
Study Completion Date2028-09-01

Terms related to this study

Keywords Provided by Researchers

  • Photobiomodulation
  • Recovery
  • Wellness

Additional Relevant MeSH Terms

  • Physiological Wellness